Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
HIV Med ; 10(4): 236-45, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19178591

RESUMEN

OBJECTIVE: We aimed to retrieve the vital status of patients lost to follow-up (LFU), with no further visits for at least 12 months, for the 34,835 patients in the Agence Nationale de Recherche sur le SIDA CO4 French Hospital Database on HIV (ANRS CO4 FHDH) seen in 1999 and to examine how loss to follow-up might influence estimates of survival and the impact of delayed access to care (DAC) on survival. METHODS: The status of LFU patients was established by using the mid-2006 update of the FHDH in which their status 12 months after loss to follow-up was added when available and by matching with the Mortalité 2000-Epidemiological Centre for Medical Causes of Death (CépiDc) database, which included HIV-infected patients dying in 2000. We compared Kaplan-Meier and hazard ratio (HR) estimates before and after correction for the status of LFU patients. RESULTS: In the mid-2006 updated FHDH, of the patients seen in 1999, 7.5% were LFU: of these, 2.1% later returned for follow-up, with a median time without follow-up in an FHDH centre of 3.5 years, and 5.4% had no further FHDH visits whatsoever, of whom 29.8% died according to Mortalité 2000-CépiDc. After correction, the estimated 1-year survival rates following enrolment in 1999 differed between the original and updated analyses (97.1 vs. 95.9%, respectively; P=0.017); the estimates of mortality HRs associated with DAC did not differ during the first 6 months, but did differ for the 6-18-month period. CONCLUSIONS: Among LFU patients, 28.1% returned to follow-up after several years and at least 21.4% died, which led to a slight overestimation of both survival and the impact of DAC on survival.


Asunto(s)
Bases de Datos Factuales/estadística & datos numéricos , Certificado de Defunción , Infecciones por VIH/mortalidad , Accesibilidad a los Servicios de Salud/estadística & datos numéricos , Pacientes Desistentes del Tratamiento/estadística & datos numéricos , Adulto , África del Sur del Sahara/etnología , Sesgo , Causas de Muerte , Estudios de Cohortes , Femenino , Francia/epidemiología , Guyana Francesa/epidemiología , Infecciones por VIH/etnología , Hospitales/estadística & datos numéricos , Humanos , Estimación de Kaplan-Meier , Masculino , Embarazo , Complicaciones Infecciosas del Embarazo/mortalidad , Modelos de Riesgos Proporcionales , Indias Occidentales/epidemiología
2.
Med Mal Infect ; 34(7): 286-92, 2004 Jul.
Artículo en Francés | MEDLINE | ID: mdl-15679232

RESUMEN

OBJECTIVE: The survey "Mortality 2000" had for aim to describe the distribution of causes of death in HIV-infected adults in France. METHOD: Hospital wards involved in the management of HIV infection prospectively reported deaths occurring in 2000. The causes of death were documented using a standardized questionnaire. RESULTS: In French Guyana and the French West Indies the five referent wards reported 81 deaths. The main underlying causes of death were AIDS-related (67%), non-AIDS and non-hepatitis related cancer (9%), cardiovascular disease (7%), bacterial infections (5%), and end stage liver disease (4%). Among AIDS-related deaths, the more frequent diseases were histoplasmosis and toxoplasmosis in Guyana and atypical mycobacterial infection, tuberculosis, and cytomegalovirus disease in the West Indies. Median age was 43 years, transmission of HIV infection was heterosexual in 79%; 56% lived in poor socio-economic conditions, and 30% were born abroad. One out of five had been recently diagnosed with HIV infection and one out of three had never received antiretroviral treatment. CONCLUSION: In 2000, two in three death cases in HIV-infected adults were AIDS-related in French Guyana and the French West Indies. Improved strategies for screening HIV infection before the occurrence of AIDS are still needed taking into consideration poor socio-economic and migrant conditions.


Asunto(s)
Infecciones por VIH/mortalidad , Adulto , Terapia Antirretroviral Altamente Activa , Causas de Muerte , Femenino , Guyana Francesa , Infecciones por VIH/tratamiento farmacológico , Humanos , Masculino , Estudios Prospectivos , Estadísticas Vitales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA